EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases

Verónica Pulito-Cueto iD, Sara Remuzgo-Martínez iD, Fernanda Genre, Belén Atienza-Mateo iD, Víctor M Mora-Cuesta iD, David Iturbe-Fernández, Leticia Lera-Gómez, María Sebastián Mora-Gil, Virginia Portilla, Alfonso Corrales, Ricardo Blanco, José M Cifrián und 2 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241512518 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Verónica Pulito-Cueto und 13 weiteren Autor:innen. Beteiligte Einrichtung: Immunopathology Group, Marqués de Valdecilla University Hospital-Marqués de Valdecilla Research Institute (IDIVAL), 39011 Santander, Spain. Hauptthemen laut MEDLINE: Lung Diseases, Interstitial, Idiopathic Pulmonary Fibrosis, Autoimmune Diseases, Arthritis, Rheumatoid. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: ISCIII-ESF, ISCIII, ESF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interstitial lung disease (ILD) constitutes the most critical comorbidity in autoimmune diseases (ADs) and its early diagnosis remains a challenge for clinicians. Accordingly, we evaluated whether E-selectin, ICAM-1, and ET-1, key molecules in endothelial damage, could be useful biomarkers for the detection of AD-ILD+. We recruited patients with rheumatoid arthritis (RA)-ILD+ (n = 21) and systemic sclerosis (SSc)-ILD+ (n = 21). We included comparison groups of patients: RA-ILD− (n = 25), SSc-ILD− (n = 20), and idiopathic pulmonary fibrosis (IPF) (n = 21). Serum levels of these proteins were determined by ELISA. E-selectin, ICAM-1, and ET-1 serum levels were increased in RA-ILD+ and IPF patients in comparison to RA-ILD− patients. Additionally, SSc-ILD+ and IPF patients exhibited higher ICAM-1 levels than those with SSc-ILD−. The ability of E-selectin, ICAM-1, and ET-1 to discriminate RA-ILD+ from RA-ILD− patients, and ICAM-1 to distinguish SSc-ILD+ from SSc-ILD− patients was confirmed using ROC curve analysis. Furthermore, elevated levels of ET-1 and E-selectin correlated with lung function decline in RA-ILD+ and SSc-ILD+ patients, respectively. In conclusion, our findings support the relevant role of E-selectin, ICAM-1, and ET-1 in RA-ILD+ patients as well as of ICAM-1 in SSc-ILD+ patients, constituting potential screening blood biomarkers of ILD in AD. Moreover, this study suggests ET-1 and E-selectin as possible indicators of worsening lung function in RA-ILD+ and SSc-ILD+ patients, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung Diseases, InterstitialIdiopathic Pulmonary FibrosisAutoimmune DiseasesArthritis, RheumatoidScleroderma, SystemicHumansIntercellular Adhesion Molecule-1E-SelectinBiomarkersLung

Stichwörter der Autor:innen

E-selectinET-1ICAM-1autoimmune diseasesbiomarkersinterstitial lung diseasepulmonary fibrosisrheumatoid arthritissystemic sclerosis

Substanzen

Intercellular Adhesion Molecule-1E-SelectinBiomarkers

Autor:innen und Institutionen

  • Immunopathology Group, Marqués de Valdecilla University Hospital-Marqués de Valdecilla Research Institute (IDIVAL), 39011 Santander, Spain.
  • Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
  • Marqués de Valdecilla Research Institute (IDIVAL), 39011 Santander, Spain.
  • Department of Pneumology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
  • Department of Microbiology, Hospital Universitario Marqués de Valdecilla, 39008 Santander, Spain.
  • School of Medicine, Universidad de Cantabria, 39011 Santander, Spain.

ORCID-Profile: Verónica Pulito-Cueto, Sara Remuzgo-Martínez, Belén Atienza-Mateo, Víctor M Mora-Cuesta, Miguel A González-Gay, Raquel López-Mejías

Förderung

  • ISCIII-ESF
  • ISCIII
  • ESF

Zitieren

APA

Pulito-Cueto, V., Remuzgo-Martínez, S., Genre, F., Atienza-Mateo, B., Mora-Cuesta, V. M., Iturbe-Fernández, D., Lera-Gómez, L., Mora-Gil, M. S., Portilla, V., Corrales, A., Blanco, R., Cifrián, J. M., González-Gay, M. A., & López-Mejías, R. (2023). E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241512518

Vancouver

Pulito-Cueto V, Remuzgo-Martínez S, Genre F, Atienza-Mateo B, Mora-Cuesta VM, Iturbe-Fernández D, et al. E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241512518

BibTeX
@article{PulitoCueto2023,
  author = {Pulito-Cueto, Verónica and Remuzgo-Martínez, Sara and Genre, Fernanda and Atienza-Mateo, Belén and Mora-Cuesta, Víctor M and Iturbe-Fernández, David and Lera-Gómez, Leticia and Mora-Gil, María Sebastián and Portilla, Virginia and Corrales, Alfonso and Blanco, Ricardo and Cifrián, José M and González-Gay, Miguel A and López-Mejías, Raquel},
  title = {E-Selectin, ICAM-1, and ET-1 Biomarkers Address the Concern of the Challenging Diagnosis of Interstitial Lung Disease in Patients with Autoimmune Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241512518}
}
Kostenlos starten →